Author:
Sadeghniiat-Haghighi Khosro,Akbarpour Samaneh,Behkar Atefeh,Moradzadeh Rahmatollah,Alemohammad Zahra Banafsheh,Forouzan Nazanin,Mouseli Ali,Amirifard Hamed,Najafi Arezu
Abstract
AbstractReliable obstructive sleep apnea (OSA) prevalence information in Iran is lacking due to inconsistent local study results. To estimate OSA prevalence and identify clinical phenotypes, we conducted a nationally representative study using multi-stage random cluster sampling. We recruited 3198 individuals and extrapolated the results to the entire Iranian population using complex sample survey analyses. We identified 3 clinical phenotypes as “sleepy,” “insomnia,” and “restless legs syndrome (RLS).” The prevalence of OSA was 28.7% (95%CI: 26.8–30.6). The prevalence of “sleepy,” “insomnia,” and “RLS” phenotypes were 82.3%, 77.8%, and 36.5% in women, and 64.8%, 67.5%, and 17.9% in men, respectively. “Sleepy” and “insomnia” phenotypes overlapped the most. Age (OR: 1.9), male sex (OR: 3.8), BMI (OR: 1.13), neck circumference (OR: 1.3), RLS (OR: 2.0), and insomnia (OR: 2.3) were significant OSA predictors (p-values: 0.001). In men, “sleepy” phenotype was associated with youth and unmarried status but not in women. The “insomnia” phenotype was associated with shorter sleep duration in women; cardiovascular diseases (CVD), urban residency, and shorter sleep duration in men. “RLS” phenotype was associated with shorter sleep duration and CVD in women and older age, lower educational level, CVD, and hypertension in men. The findings point to the need for funding of OSA screening in Iran, for a different assessment of men and women, and for future sleep research to consider overlapping phenotypes.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Sullivan, F. Hidden health crisis costing america billions: Underdiagnosing and undertreating obstructive sleep apnea draining healthcare system. Am. Acad. Sleep Med. 12(8), 1075–1077 (2016).
2. Kapur, V. et al. The medical cost of undiagnosed sleep apnea. Sleep 22(6), 749–755 (1999).
3. Garbarino, S., Magnavita, N., Sanna, A. & Bragazzi, N. L. Estimating the hidden burden of obstructive sleep apnoea: Challenges and pitfalls. Lancet Respir. Med. 8(1), e1 (2020).
4. Benjafield, A. V. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. Lancet Respir. Med. 7(8), 687–698 (2019).
5. Amra, B., Farajzadegan, Z., Golshan, M., Fietze, I. & Penzel, T. Prevalence of sleep apnea-related symptoms in a Persian population. Sleep Breath. 15(3), 425–429 (2011).